A pox on thee! Manipulation of the host immune system by myxoma virus and implications for viral-host co-adaptation

Virus Research

Volumn 88, Issue 1-2, 2002, Pages 17-33

  Zúñiga, Martha C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Host viral co evalution; Immunomodulatory protein; Myxoma virus

Indexed keywords

BETA CHEMOKINE; GAMMA INTERFERON RECEPTOR; GENE PRODUCT; IMMUNOMODULATING AGENT; SERINE PROTEINASE INHIBITOR; TUMOR NECROSIS FACTOR RECEPTOR;

ADAPTATION; APOPTOSIS; AUSTRALIA; HOST; IMMUNE SYSTEM; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; KNOCKOUT GENE; MORTALITY; MYXOMA VIRUS; MYXOMATOSIS; NONHUMAN; ORYCTOLAGUS CUNICULUS; PATHOGENESIS; POXVIRUS; PRIORITY JOURNAL; RABBIT; REVIEW; SKIN DEFECT; SYLVILOGUS BRASILIENSIS; T LYMPHOCYTE; VIRUS INFECTION; VIRUS ISOLATION; VIRUS MUTATION;

ADAPTATION, PHYSIOLOGICAL; ADJUVANTS, IMMUNOLOGIC; ANIMALS; IMMUNE SYSTEM; MYXOMA VIRUS; MYXOMATOSIS, INFECTIOUS; RABBITS; VIRAL PROTEINS; VIRULENCE;

MYXOMA VIRUS; ORYCTOLAGUS CUNICULUS; POXVIRIDAE;

EID: 0036709720     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-1702(02)00118-1     Document Type: Review

References (64)

1. Anderson R.M., May R.M. Coevolution of hosts and parasites. Parasitology. 85:(Part 2):1982;411-426.
2. Andrade M.A., Perez-Iratxeta C., Ponting C.P. Protein repeats: structures, functions, and evolution. J. Struct. Biol. 134:(2-3):2001;117-131.
3. Annaert W.G., Becker B., Kistner U., Reth M., Jahn R. Export of cellubrevin from the endoplasmic reticulum is controlled by BAP31. J. Cell. Biol. 139:(6):1997;1397-1410.
4. Barber G.N. Host defense, viruses and apoptosis. Cell Death Differ. 8:(2):2001;113-126.
5. Barrett J.W., Cao J.X., Hota-Mitchell S., McFadden G. Immunomodulatory proteins of myxoma virus. Semin. Immunol. 13:(1):2001;73-84.
6. Barry M., Hnatiuk S., Mossman K., Lee S.F., Boshkov L., McFadden G. The myxoma virus M-T4 gene encodes a novel RDEL-containing protein that is retained within the endoplasmic reticulum and is important for the productive infection of lymphocytes. Virology. 239:(2):1997;360-377.
7. Barry M., Lee S.F., Boshkov L., McFadden G. Myxoma virus induces extensive CD4 downregulation and dissociation of p56lck in infected rabbit CD4+ T lymphocytes. J. Virol. 69:(9):1995;5243-5251.
8. Baud V., Karin M. Signal transduction by tumor necrosis factor and its relatives. Trends Cell. Biol. 11:(9):2001;372-377.
9. Best S.M., Collins S.V., Kerr P.J. Coevolution of host and virus: cellular localization of virus in myxoma virus infection of resistant and susceptible European rabbits. Virology. 277:(1):2000;76-91.
10. Best S.M., Kerr P.J. Coevolution of host and virus: the pathogenesis of virulent and attenuated strains of myxoma virus in resistant and susceptible European rabbits. Virology. 267:(1):2000;36-48.
11. Boya P., Roques B., Kroemer G. New EMBO members' review: viral and bacterial proteins regulating apoptosis at the mitochondrial level. Embo. J. 20:(16):2001;4325-4331.
12. Cameron C., Hota-Mitchell S., Chen L., Barrett J., Cao J.X., Macaulay C., Willer D., Evans D., McFadden G. The complete DNA sequence of myxoma virus. Virology. 264:(2):1999;298-318.
13. Cox G., Crossley J., Xing Z. Macrophage engulfment of apoptotic neutrophils contributes to the resolution of acute pulmonary inflammation in vivo. Am. J. Respir. Cell. Mol. Biol. 12:(2):1995;232-237.
14. Cudmore S., Reckmann I., Way M. Viral manipulations of the actin cytoskeleton. Trends Microbiol. 5:(4):1997;142-148.
15. Drake J.W., Charlesworth B., Charlesworth D., Crow J.F. Rates of spontaneous mutation. Genetics. 148:(4):1998;1667-1686.
16. Everett H., Barry M., Lee S.F., Sun X., Graham K., Stone J., Bleackley R.C., McFadden G. M11L: a novel mitochondria-localized protein of myxoma virus that blocks apoptosis of infected leukocytes. J. Exp. Med. 191:(9):2000;1487-1498.
17. Everett H., McFadden G. Viruses and apoptosis: meddling with mitochondria. Virology. 288:2001;1-7.
18. Fenner F., Ratcliffe F.N. Myxomatosis. 1965;Cambridge University Press, London.
19. Frank M.M., Fries L.F. The role of complement in inflammation and phagocytosis. Immunol. Today. 12:(9):1991;322-326.
20. Graham K.A., Lalani A.S., Macen J.L., Ness T.L., Barry M., Liu L.Y., Lucas A., Clark-Lewis I., Moyer R.W., McFadden G. The T1/35kDa family of poxvirus-secreted proteins bind chemokines and modulate leukocyte influx into virus-infected tissues. Virology. 229:(1):1997;12-24.
21. Grosenbach D.W., Hruby D.E. Biology of vaccinia virus acylproteins. Front. Biosci. 3:1998;d354-d364.
22. Guerin J.L., Gelfi J., Camus C., Delverdier M., Whisstock J.C., Amardeihl M.F., Py R., Bertagnoli S., Messud-Petit F. Characterization and functional analysis of Serp3: a novel myxoma virus-encoded serpin involved in virulence. J. Gen. Virol. 82:(Part 6):2001;1407-1417.
23. Hnatiuk S., Barry M., Zeng W., Liu L., Lucas A., Percy D., McFadden G. Role of the C-terminal RDEL motif of the myxoma virus M-T4 protein in terms of apoptosis regulation and viral pathogenesis. Virology. 263:(2):1999;290-306.
24. Kroemer G., Reed J.C. Mitochondrial control of cell death. Nat. Med. 6:(5):2000;513-519.
25. Lalani A.S., Graham K., Mossman K., Rajarathnam K., Clark-Lewis I., Kelvin D., McFadden G. The purified myxoma virus gamma interferon receptor homolog M-T7 interacts with the heparin-binding domains of chemokines. J. Virol. 71:(6):1997;4356-4363.
26. Lalani A.S., Masters J., Graham K., Liu L., Lucas A., McFadden G. Role of the myxoma virus soluble CC-chemokine inhibitor glycoprotein, M-T1, during myxoma virus pathogenesis. Virology. 256:(2):1999a;233-245.
27. Lalani A.S., Masters J., Zeng W., Barrett J., Pannu R., Everett H., Arendt C.W., McFadden G. Use of chemokine receptors by poxviruses. Science. 286:(5446):1999b;1968-1971.
28. Lalani A.S., Ness T.L., Singh R., Harrison J.K., Seet B.T., Kelvin D.J., McFadden G., Moyer R.W. Functional comparisons among members of the poxvirus T1/35kDa family of soluble CC-chemokine inhibitor glycoproteins. Virology. 250:(1):1998;173-184.
29. Lomas D.A., Evans D.L., Upton C., McFadden G., Carrell R.W. Inhibition of plasmin, urokinase, tissue plasminogen activator, and C1S by a myxoma virus serine proteinase inhibitor. J. Biol. Chem. 268:(1):1993;516-521.
30. Macen J.L., Graham K.A., Lee S.F., Schreiber M., Boshkov L.K., McFadden G. Expression of the myxoma virus tumor necrosis factor receptor homologue and M11L genes is required to prevent virus-induced apoptosis in infected rabbit T lymphocytes. Virology. 218:(1):1996;232-237.
31. Macen J.L., Upton C., Nation N., McFadden G. SERP1, a serine proteinase inhibitor encoded by myxoma virus, is a secreted glycoprotein that interferes with inflammation. Virology. 195:(2):1993;348-363.
32. Mahalingam S., Karupiah G. Modulation of chemokines by poxvirus infections. Curr. Opin. Immunol. 12:(4):2000;409-412.
33. Manley H.A., Lennon V.A. Endoplasmic reticulum membrane-sorting protein of lymphocytes (BAP31) is highly expressed in neurons and discrete endocrine cells. J. Histochem. Cytochem. 49:(10):2001;1235-1243.
34. Messud-Petit F., Gelfi J., Delverdier M., Amardeilh M.F., Py R., Sutter G., Bertagnoli S. Serp2, an inhibitor of the interleukin-1beta-converting enzyme, is critical in the pathobiology of myxoma virus. J. Virol. 72:(10):1998;7830-7839.
35. Mossman K., Lee S.F., Barry M., Boshkov L., McFadden G. Disruption of M-T5, a novel myxoma virus gene member of poxvirus host range superfamily, results in dramatic attenuation of myxomatosis in infected European rabbits. J. Virol. 70:(7):1996a;4394-4410.
36. Mossman K., Nation P., Macen J., Garbutt M., Lucas A., McFadden G. Myxoma virus M-T7, a secreted homolog of the interferon-gamma receptor, is a critical virulence factor for the development of myxomatosis in European rabbits. Virology. 215:(1):1996b;17-30.
37. Murdoch C., Finn A. Chemokine receptors and their role in inflammation and infectious diseases. Blood. 95:(10):2000;3032-3043.
38. Nakamura K., Bossy-Wetzel E., Burns K., Fadel M.P., Lozyk M., Goping I.S., Opas M., Bleackley R.C., Green D.R., Michalak M. Changes in endoplasmic reticulum luminal environment affect cell sensitivity to apoptosis. J. Cell. Biol. 150:(4):2000;731-740.
39. Ng F.W., Nguyen M., Kwan T., Branton P.E., Nicholson D.W., Cromlish J.A., Shore G.C. p28 Bap31, a Bcl-2/Bcl-XL- and procaspase-8-associated protein in the endoplasmic reticulum. J. Cell. Biol. 139:(2):1997;327-338.
40. Ng F.W., Shore G.C. Bcl-XL cooperatively associates with the Bap31 complex in the endoplasmic reticulum, dependent on procaspase-8 and Ced-4 adaptor. J. Biol. Chem. 273:(6):1998;3140-3143.
41. Nguyen M., Breckenridge D.G., Ducret A., Shore G.C. Caspase-resistant BAP31 inhibits fas-mediated apoptotic membrane fragmentation and release of cytochrome c from mitochondria. Mol. Cell. Biol. 20:(18):2000;6731-6740.
42. Opgenorth A., Graham K., Nation N., Strayer D., McFadden G. Deletion analysis of two tandemly arranged virulence genes in myxoma virus, M11L and myxoma growth factor. J. Virol. 66:(8):1992a;4720-4731.
43. Opgenorth A., Nation N., Graham K., McFadden G. Transforming growth factor alpha, Shope fibroma growth factor, and vaccinia growth factor can replace myxoma growth factor in the induction of myxomatosis in rabbits. Virology. 192:(2):1993;701-709.
44. Opgenorth A., Strayer D., Upton C., McFadden G. Deletion of the growth factor gene related to EGF and TGF alpha reduces virulence of malignant rabbit fibroma virus. Virology. 186:(1):1992b;175-191.
45. Petit F., Bertagnoli S., Gelfi J., Fassy F., Boucraut-Baralon C., Milon A. Characterization of a myxoma virus-encoded serpin-like protein with activity against interleukin-1 beta-converting enzyme. J. Virol. 70:(9):1996;5860-5866.
46. Potempa J., Korzus E., Travis J. The serpin superfamily of proteinase inhibitors: structure, function, and regulation. J. Biol. Chem. 269:(23):1994;15957-15960.
47. Rao R.V., Hermel E., Castro-Obregon S., del Rio G., Ellerby L.M., Ellerby H.M., Bredesen D.E. Coupling endoplasmic reticulum stress to the cell death program. Mechanism of caspase activation. J. Biol. Chem. 276:(36):2001;33869-33874.
48. Ren Y., Savill J. Proinflammatory cytokines potentiate thrombospondin-mediated phagocytosis of neutrophils undergoing apoptosis. J. Immunol. 154:(5):1995;2366-2374.
49. Ren Y., Stuart L., Lindberg F.P., Rosenkranz A.R., Chen Y., Mayadas T.N., Savill J. Nonphlogistic clearance of late apoptotic neutrophils by macrophages: efficient phagocytosis independent of beta 2 integrins. J. Immunol. 166:(7):2001;4743-4750.
50. Roger M. Influence of host genes on HIV-1 disease progression. FASEB J. 12:(9):1998;625-632.
51. Russell R.J., Robbins S.J. Cloning and molecular characterization of the myxoma virus genome. Virology. 170:(1):1989;147-159.
52. Saint K.M., French N., Kerr P. Genetic variation in Australian isolates of myxoma virus: an evolutionary and epidemiological study. Arch. Virol. 146:(6):2001;1105-1123.
53. Schreiber M., Rajarathnam K., McFadden G. Myxoma virus T2 protein, a tumor necrosis factor (TNF) receptor homolog, is secreted as a monomer and dimer that each bind rabbit TNFalpha, but the dimer is a more potent TNF inhibitor. J. Biol. Chem. 271:(23):1996;13333-13341.
54. Schreiber M., Sedger L., McFadden G. Distinct domains of M-T2, the myxoma virus tumor necrosis factor (TNF) receptor homolog, mediate extracellular TNF binding and intracellular apoptosis inhibition. J. Virol. 71:(3):1997;2171-2181.
55. Sodeik B., Krijnse-Locker J. Assembly of vaccinia virus revisited: de novo membrane synthesis or acquisition from the host? Trends Microbiol. 10:(1):2002;15-124.
56. Spiliotis E.T., Osorio M., Zuniga M.C., Edidin M. Selective export of MHC class I molecules from the ER after their dissociation from TAP. Immunity. 13:(6):2000;841-851.
57. Turner P.C., Sancho M.C., Thoennes S.R., Caputo A., Bleackley R.C., Moyer R.W. Myxoma virus Serp2 is a weak inhibitor of granzyme B and interleukin-1beta-converting enzyme in vitro and unlike CrmA cannot block apoptosis in cowpox virus-infected cells. J. Virol. 73:(8):1999;6394-6404.
58. Upton C., Macen J.L., Schreiber M., McFadden G. Myxoma virus expresses a secreted protein with homology to the tumor necrosis factor receptor gene family that contributes to viral virulence. Virology. 184:(1):1991;370-382.
59. Upton C., Macen J.L., Wishart D.S., McFadden G. Myxoma virus and malignant rabbit fibroma virus encode a serpin-like protein important for virus virulence. Virology. 179:(2):1990;618-631.
60. Upton C., Mossman K., McFadden G. Encoding of a homolog of the IFN-gamma receptor by myxoma virus. Science. 258:(5086):1992;1369-1372.
61. Yoshie O., Imai T., Nomiyama H. Chemokines in immunity. Adv. Immunol. 78:2001;57-110.
62. Zúñiga M.C. Myxoma down-regulation of cell-surface MHC class I: unplanned detours and unexpected accidents on the way to the plasma membrane. Recent Res. Dev. Virol. 3:2001;191-207.
63. Zúñiga M.C., Wang H., Barry M., McFadden G. Endosomal/lysosomal retention and degradation of major histocompatibility complex class I molecules is induced by myxoma virus. Virology. 261:(2):1999a;180-192.
64. Zúñiga, M.C., Wang, H., Barry, M., McFadden, G. 1999b. Myxoma virus abrogates cell-surface expression of MHC I by multiple mechanisms. In: Jameel, S. and Villarreal, L. (Eds.), Advances in Animal Virology. Oxford and IBH Publishing Company, New Delhi, pp. 309-322.